DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Frederiksen MT, Ainsworth MA, Brynskov J. et al.
Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD.

Inflamm Bowel Dis 2014;
20: 1714-1721

Frederiksen MT, Ainsworth MA, Brynskov J. et al.
Antibodies against infliximab are associated with de novo development of antibodies to adalimumab and therapeutic failure in infliximab-to-adalimumab switchers with IBD.

Inflamm Bowel Dis 2014;
20: 1714-1721

Download Bibliographical Data

Search in:
Access: